LifeStance Health Gr's miss on EPS estimates by -33.0% is likely to negatively impact investor sentiment, especially considering the company's history of missing EPS estimates and the subsequent 3.0% drop in share price the following day after last quarter's earnings. The increase in revenue may provide some positive outlook, but the consistent misses on earnings expectations are a significant concern.